ARVN - Arvinas GAAP EPS of -$1.18 beats by $0.39 revenue of $34.6M misses by $5.45M
2023-11-07 07:59:53 ET
More on Arvinas
- Arvinas' Potential In Treating ER+, HER2- Breast Cancer
- Seeking Alpha’s Quant Rating on Arvinas
- Historical earnings data for Arvinas
- Financial information for Arvinas
For further details see:
Arvinas GAAP EPS of -$1.18 beats by $0.39, revenue of $34.6M misses by $5.45M